Sökning: onr:"swepub:oai:gup.ub.gu.se/298598" > Deep phenotyping of...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05484naa a2201129 4500 | |
001 | oai:gup.ub.gu.se/298598 | |
003 | SwePub | |
008 | 240528s2020 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/2985982 URI |
024 | 7 | a https://doi.org/10.1038/s41467-020-18849-z2 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Burn, E.4 aut |
245 | 1 0 | a Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study |
264 | c 2020-10-06 | |
264 | 1 | b Springer Science and Business Media LLC,c 2020 |
520 | a Comorbid conditions appear to be common among individuals hospitalised with coronavirus disease 2019 (COVID-19) but estimates of prevalence vary and little is known about the prior medication use of patients. Here, we describe the characteristics of adults hospitalised with COVID-19 and compare them with influenza patients. We include 34,128 (US: 8362, South Korea: 7341, Spain: 18,425) COVID-19 patients, summarising between 4811 and 11,643 unique aggregate characteristics. COVID-19 patients have been majority male in the US and Spain, but predominantly female in South Korea. Age profiles vary across data sources. Compared to 84,585 individuals hospitalised with influenza in 2014-19, COVID-19 patients have more typically been male, younger, and with fewer comorbidities and lower medication use. While protecting groups vulnerable to influenza is likely a useful starting point in the response to COVID-19, strategies will likely need to be broadened to reflect the particular characteristics of individuals being hospitalised with COVID-19. Detailed knowledge of the characteristics of COVID-19 patients helps with public health planning. Here, the authors use routinely-collected data from seven databases in three countries to describe the characteristics of >30,000 patients admitted with COVID-19 and compare them with those admitted for influenza in previous years. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Infektionsmedicin0 (SwePub)302092 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Infectious Medicine0 (SwePub)302092 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi0 (SwePub)303022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Public Health, Global Health, Social Medicine and Epidemiology0 (SwePub)303022 hsv//eng |
700 | 1 | a You, S. C.4 aut |
700 | 1 | a Sena, A. G.4 aut |
700 | 1 | a Kostka, K.4 aut |
700 | 1 | a Abedtash, H.4 aut |
700 | 1 | a Abrahao, M. T. F.4 aut |
700 | 1 | a Alberga, A.4 aut |
700 | 1 | a Alghoul, H.4 aut |
700 | 1 | a Alser, O.4 aut |
700 | 1 | a Alshammari, T. M.4 aut |
700 | 1 | a Aragon, M.4 aut |
700 | 1 | a Areia, C.4 aut |
700 | 1 | a Banda, J. M.4 aut |
700 | 1 | a Cho, J.4 aut |
700 | 1 | a Culhane, A. C.4 aut |
700 | 1 | a Davydov, A.4 aut |
700 | 1 | a DeFalco, F. J.4 aut |
700 | 1 | a Duarte-Salles, T.4 aut |
700 | 1 | a DuVall, S.4 aut |
700 | 1 | a Falconer, T.4 aut |
700 | 1 | a Fernandez-Bertolin, S.4 aut |
700 | 1 | a Gao, W. H.4 aut |
700 | 1 | a Golozar, A.4 aut |
700 | 1 | a Hardin, J.4 aut |
700 | 1 | a Hripcsak, G.4 aut |
700 | 1 | a Huser, V.4 aut |
700 | 1 | a Jeon, H.4 aut |
700 | 1 | a Jing, Y. H.4 aut |
700 | 1 | a Jung, C. Y.4 aut |
700 | 1 | a Kaas-Hansen, B. S.4 aut |
700 | 1 | a Kaduk, D.4 aut |
700 | 1 | a Kent, S.4 aut |
700 | 1 | a Kim, Y.4 aut |
700 | 1 | a Kolovos, S.4 aut |
700 | 1 | a Lane, J. C. E.4 aut |
700 | 1 | a Lee, H.4 aut |
700 | 1 | a Lynch, K. E.4 aut |
700 | 1 | a Makadia, R.4 aut |
700 | 1 | a Matheny, M. E.4 aut |
700 | 1 | a Mehta, P. P.4 aut |
700 | 1 | a Morales, D. R.4 aut |
700 | 1 | a Natarajan, K.4 aut |
700 | 1 | a Nyberg, Fredrik,d 1961u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för samhällsmedicin och folkhälsa,Institute of Medicine, School of Public Health and Community Medicine4 aut0 (Swepub:gu)xnybef |
700 | 1 | a Ostropolets, A.4 aut |
700 | 1 | a Park, R. W.4 aut |
700 | 1 | a Park, J.4 aut |
700 | 1 | a Posada, J. D.4 aut |
700 | 1 | a Prats-Uribe, A.4 aut |
700 | 1 | a Rao, G.4 aut |
700 | 1 | a Reich, C.4 aut |
700 | 1 | a Rho, Y.4 aut |
700 | 1 | a Rijnbeek, P.4 aut |
700 | 1 | a Schilling, L. M.4 aut |
700 | 1 | a Schuemie, M.4 aut |
700 | 1 | a Shah, N. H.4 aut |
700 | 1 | a Shoaibi, A.4 aut |
700 | 1 | a Song, S.4 aut |
700 | 1 | a Spotnitz, M.4 aut |
700 | 1 | a Suchard, M. A.4 aut |
700 | 1 | a Swerdel, J. N.4 aut |
700 | 1 | a Vizcaya, D.4 aut |
700 | 1 | a Volpe, S.4 aut |
700 | 1 | a Wen, H. N.4 aut |
700 | 1 | a Williams, A. E.4 aut |
700 | 1 | a Yimer, B. B.4 aut |
700 | 1 | a Zhang, L.4 aut |
700 | 1 | a Zhuk, O.4 aut |
700 | 1 | a Prieto-Alhambra, D.4 aut |
700 | 1 | a Ryan, P.4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för medicin, avdelningen för samhällsmedicin och folkhälsa4 org |
773 | 0 | t Nature Communicationsd : Springer Science and Business Media LLCg 11:1q 11:1x 2041-1723 |
856 | 4 | u https://www.nature.com/articles/s41467-020-18849-z.pdf |
856 | 4 8 | u https://gup.ub.gu.se/publication/298598 |
856 | 4 8 | u https://doi.org/10.1038/s41467-020-18849-z |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.